Ospedale “Giuseppe Mazzini” - Teramo

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Colorectal cancer1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Fondazione Ricerca Traslazionale2 trials
• IRCCS Istituto Nazionale Tumori Fondazione Pascale1 trial

Running trials

• Recruiting

  Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left sided RAS/B-RAF wild-type metastatic colorectal cancer (IMPROVE-2 trial)

  2023-509551-14-00· Phase 3· IRCCS Istituto Nazionale Tumori Fondazione Pascale· Source

• Recruiting

  A randomized, non-comparative, phase II study investigating the best epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) sequence in advanced or metastatic non-small-cell lung cancer (NSCLC) harboring EGFR mutations

  NCT04811001· Phase 2· Fondazione Ricerca Traslazionale· Source

• Recruiting

  Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-small-cell lung cancer patients

  2024-517200-10-00· Phase 2· Fondazione Ricerca Traslazionale· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Lung cancer1 recruiting